Recommend Epigenetics to your librarian today. Download form here.

Sign up for Table of Contents Alerts.

The official journal of the Epigenetics Society.

Email this page

Print this page

Review

Involvement of the chromatin-remodeling factor BRG1/SMARCA4 in human cancer

Pedro P. Medina and Montse Sanchez-Cespedes

Purchase article for $19

Subscribe to this journal for $79/year

The SWI/SNF complex is a chromatin-remodeling complex that uses the energy of ATP hydrolysis to modify chromatin structure in order to regulate gene expression. The SWI/SNF complex is evolutionarily conserved in all eukaryotes and is comprised of a catalytic subunit, either of BRG1 (also known as SMARCA4) or of BRM (also known as SMARCA2), and a variety of associated proteins that can modulate the recruitment of the complex and its activity. Key observations link the SWI/SNF complex with cancer. First, two of its subunits (SNF5 and BRG1) bear cancer-inactivating mutations and thus are bona fide tumor suppressors. The SNF5 gene is biallelically inactivated in malignant rhabdoid tumors (MRTs) whereas BRG1 is mutated in cancer cell lines of several types, such as those of the breast, prostate, lung, pancreas and colon. Second, mice heterozygous for mutations at Snf5 and Brg1 are cancer-prone, and, third, BRG1 binds or is related to important tumor-suppressor proteins. The present review focuses on the biological function and genetics of BRG1, particularly with respect to its role as a tumor suppressor.

Authors

Pedro P. Medina

Yale University

Montse Sanchez-Cespedes

Spanish National Cancer Centre (CNIO)

Purchase article for $19

Subscribe to this journal for $79/year